Enkai Cell Technology

Shanghai, China · Founded 2020 · Privately Held (backing)

Researcher of immune cell drugs designed for tumour patients. Enkai Cell Technology is based in Shanghai, China and was founded in 2020. It has raised $28.9 million.

Last price · $/share

—

Implied valuation

—

Total raised

$28.9M

Last round

—

How much has Enkai Cell Technology raised?

$28.9Macross 0 recorded rounds

Free account

More of Enkai Cell Technology with a free account

·The complete investor list: 11 names
·Watch Enkai Cell Technology: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Enkai Cell Technology investors

11 investors are on record for Enkai Cell Technology, including The Chinese Academy of Sciences Venture Capital Management, Yijin Capital, 3Sbio and Beijing FOF Capital.

For fundraisers

Raising for a company like Enkai Cell Technology?

11 investors have backed Enkai Cell Technology.

See all 11 investors →

Frequently asked about Enkai Cell Technology

How much has Enkai Cell Technology raised?: Enkai Cell Technology has raised $28.9M in total across 0 recorded funding rounds.